17 Results for "

human PDI

" in MedChemExpress (MCE) Product Catalog:
Products (17)

17 Results for "human PDI" in MCE Product Catalog:

  • Targets Recommended:
8
8 Publications Verification
Cat. No.: HY-W107464
CAS No.: 2457232-14-1
Target:  

PDI

G6PDi-1 is a reversible and non-competitive glucose-6-phosphate dehydrogenase (G6PD) inhibitor with an IC50 of 0.07 μM for human G6PD. G6PDi-1 depletes NADPH most strongly in lymphocytes. G6PDi-1 markedly decreases inflammatory cytokine production in T cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70990
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Protein-Arginine Deiminase Type-4; HL-60 PAD; Peptidylarginine Deiminase IV; Protein-arginine Deiminase type IV; PADI4; PADI5; PDI5
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P71917
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Cellular thyroid hormone binding protein; Cellular thyroid hormone-binding protein; Collagen prolyl 4 hydroxylase beta; Disulphide Isomerase; DSI; EC 5.3.4.1; ER protein 59; ERBA2L; ERp59; GIT; P4HB; P4Hbeta; p55; PDI; PDIA1; PDIA1_human; PDIR; PHDB; PO4DB; PO4HB; PROHB; Protocollagen hydroxylase; Thbp;
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-N2163
CAS No.: 172760-03-1
Mudanpioside C is a protein disulfide isomerase (PDI) inhibitor with a human IC50 of 3.31 μM and human Kd of 3.9 μM. Mudanpioside C suppresses collagen-induced platelet aggregation, interferes with platelet activation, adhesion, and spreading. Mudanpioside C can be used for the research of cardiovascular diseases .
loading...
    loading...
Cat. No.: HY-110172
CAS No.: 1461648-55-4
Target:  

PDI

Research Areas:  

Cancer

PDI-IN-1 is a cell-permeable PDI covalent inhibitor with an IC50 of 1.7 μM against bovine PDI. PDI-IN-1 specifically modifies the Cys397 residue at the active site of human PDI, selectively labels endogenous PDI in living mammalian cancer cells, and effectively inhibits PDI-mediated insulin aggregation in vitro. PDI-IN-1 exhibits significant anti-tumor activity and inhibits the growth of various cancer cell lines .
loading...
    loading...
Cat. No.: HY-170655
Target:  

PDI Integrin

Research Areas:  

Cardiovascular Disease

PDI-IN-4 is a highly selective inhibitor of human PDI (IC50=0.48 μM) with no significant cytotoxicity. PDI-IN-4 binds to PDI in a reversible manner, not only forming a covalent bond with the Cys400 residue but also engaging in hydrophobic interactions with other residues. By inhibiting the activation of GPIIb/IIIa, PDI-IN-4 effectively blocks platelet aggregation and thrombus formation. PDI-IN-4 can serve as an important tool reagent for thrombosis-related research .
loading...
    loading...
Cat. No.: HY-163351
Research Areas:  

Cardiovascular Disease Cancer

PDI-IN-2 is a highly selective PDI inhibitor. PDI-IN-2 has an IC50 of 0.63-4.01 μM against human PDI, and exhibits higher targeting specificity compared with ERp57 and ERp72. PDI-IN-2 inhibits platelet aggregation induced by U46619, collagen and tumor cells, and also blocks platelet-promoted tumor cell proliferation as well as the growth of multiple myeloma cells. PDI-IN-2 serves as an important tool reagent for research on multiple myeloma and associated thrombosis .
loading...
    loading...
Cat. No.: HY-181573
Target:  

PDI Apoptosis

Research Areas:  

Neurological Disease Cancer

TC8026 is an allosteric-covalent inhibitor targeting protein disulfide isomerase (PDI), with an IC50 of 7 μM against human PDI. TC8026 induces endoplasmic reticulum stress-mediated apoptosis. TC8026 is a hit compound with PDI inhibitory activity identified via high-throughput screening, and it can be used for the research of glioblastoma .
loading...
    loading...
Cat. No.: HY-P704834
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PAD1; PDI1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P703022
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PAD1; PDI1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-N19464
CAS No.: 16408-78-9
Dicentrinone is an orally active PDI inhibitor with an IC50 value of 43.95 μM. Dicentrinone directly binds to PDI and suppresses cell proliferation and reduces cancer cell viability. Dicentrinone elicits anti-inflammatory and antioxidant effects by suppressing leukocyte migration, plasma leakage and paw edema, and scavenging free radicals. Dicentrinone can be used in the research of hepatoma, rheumatism and arthritis .
loading...
    loading...
Cat. No.: HY-138934
CAS No.: 1642375-66-3
Target:  

PDI

Research Areas:  

Cardiovascular Disease

Bepristat 1a is a reversible, selective protein disulfide isomerase (PDI) inhibitor with an IC50 of 0.7 μM. Bepristat 1a inhibits platelet aggregation in laser-injured mouse arterioles. Bepristat 1a is applicable for research related to thrombosis .
loading...
    loading...
Cat. No.: HY-P78738
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PADI2; PAD-H19; KIAA0994; PAD2; PDI2
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P704161
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PAD3; PDI3; UHS1; Protein-arginine deiminase type-3
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P71087
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Protein Disulfide-Isomerase; PDI; Cellular Thyroid Hormone-Binding Protein; Prolyl 4-Hydroxylase Subunit Beta; p55; P4HB; ERBA2L; PDI; PDIA1; PO4DB
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P82048
Synonyms: ERp28; ERP29_human; ERp31; HEL S 107; PDI-DB; PDIA9

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P701030
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Protein-arginine deiminase type-4; HL-60 PAD; HL60 PAD; HL-60; PAD; PAD4; PADI5; PDI5
Species:  
Source:  
loading...
    loading...
  • 1